Rifaximin in nonalcoholic fatty liver disease: hit multiple targets with a single shot.
Abdel-Razik A, Mousa N, Shabana W, Refaey M, Elzehery R, Elhelaly R, Zalata K, Abdelsalam M, Eldeeb AA, Awad M, Elgamal A, Attia A, El-Wakeel N, Eldars W.
Abdel-Razik A, et al. Among authors: mousa n.
Eur J Gastroenterol Hepatol. 2018 Oct;30(10):1237-1246. doi: 10.1097/MEG.0000000000001232.
Eur J Gastroenterol Hepatol. 2018.
PMID: 30096092
Clinical Trial.